Fibrinolytic Therapy Market
Description
Fibrinolytic Therapy Market, By Drug Type (Alteplase, Reteplase, Tenecteplase, Streptokinase, Anistreplase, Urokinase), By Indication (Acute Ischemic Stroke, Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Arterial Thrombosis, Other Thrombotic Conditions), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), By Administration (Intravenous (IV), Intra-arterial (IA)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Patient Age (Adult Patients, Pediatric Patients), By Packaging Type (Vials, Ampoules, Pre-filled Syringes), By Application (Emergency Care, Interventional Cardiology, Thrombosis Treatment, Others), By Dosage Form (Lyophilized Powder for Reconstitution, Solution for Injection), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Fibrinolytic therapy is used to dissolve blood clots that cause heart attacks or strokes. It is a lifesaving treatment, but it doesn't address underlying health problems that can lead to other serious diseases and conditions. Thrombolysis is usually given through an IV line. It is used when symptoms of a stroke or heart attack are present and not responding to other treatments, like anticoagulants and steroid medications. It can be given at home or in a hospital. Tissue plasminogen activator or alteplase, a drug that breaks down fibrin and other substances that create clots in the body, is most commonly used for thrombolysis. The drug tenecteplase is also effective in some patients, and it can be given by mouth.
Market Dynamic:
The increasing incidences of trauma and road accidents are driving the demand for antifibrinolytic drugs, which in turn is fuelling fibrinolytic therapy market growth. The growing use of these drugs in oral bleeding treatments, mainly for menorrhagia (heavy menstrual flow) is again anticipated to bolster the market growth further. Moreover, rising incidences of severe road accidents and trauma is creating demand for anti-fibrinolytic drugs, thereby propelling market growth. Furthermore, the rising adoption of these drugs for treating hemophilia and other conditions such as platelet dysfunctions, Von Willebrand diseases and haemophilia A and B is further bolstering the market growth
However, the high price of these drugs is a key factor that can hinder the industry’s growth.
Key features of the study:
This report provides in-depth analysis of the global fibrinolytic therapy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fibrinolytic therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Genentech, Inc. (Roche), Bayer AG, Boehringer Ingelheim International GmbH, Pfizer Inc., Bristol Myers Squibb Company, Novartis AG, AstraZeneca PLC, Johnson & Johnson Daiichi Sankyo Company, Limited, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global fibrinolytic therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibrinolytic therapy market
Detailed Segmentation:
Fibrinolytic Therapy Market, By Drug Type:
Alteplase
Reteplase
Tenecteplase
Streptokinase
Anistreplase
Urokinase
Fibrinolytic Therapy Market, By Indication:
Acute Ischemic Stroke
Acute Myocardial Infarction
Deep Vein Thrombosis
Pulmonary Embolism
Peripheral Arterial Thrombosis
Other Thrombotic Conditions
Fibrinolytic Therapy Market, By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Fibrinolytic Therapy Market, By Administration:
Intravenous (IV)
Intra-arterial (IA)
Fibrinolytic Therapy Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Fibrinolytic Therapy Market, By Patient Age:
Adult Patients
Pediatric Patients
Fibrinolytic Therapy Market, By Packaging Type:
Vials
Ampoules
Pre-filled Syringes
Fibrinolytic Therapy Market, By Application:
Emergency Care
Interventional Cardiology
Thrombosis Treatment
Others
Fibrinolytic Therapy Market, By Dosage Form:
Lyophilized Powder for Reconstitution
Solution for Injection
Fibrinolytic Therapy Market, By Geography:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profile
Genentech, Inc. (Roche)
Bayer AG
Boehringer Ingelheim International GmbH
Pfizer Inc.
Bristol Myers Squibb Company
Novartis AG
AstraZeneca PLC
Johnson & Johnson
Daiichi Sankyo Company, Limited
Merck & Co., Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Abbott Laboratories
Mallinckrodt Pharmaceuticals
Mitsubishi Tanabe Pharma Corporation
Table of Contents
160 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Patient Age
- Market Snapshot , By Packaging Type
- Market Snapshot, By Application
- Market Snapshot, By Dosage Form
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing incidences of trauma and road accidents
- High price of the treatment
- Growing research and development activities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Fibrinolytic Therapy Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Global Fibrinolytic Therapy Market , By Drug Type, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Alteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Reteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Tenacteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Streptokinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Anistreplase
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Urokinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 6. Global Fibrinolytic Therapy Market , By Indication, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Acute Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Acute Myocardial Infarction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Deep Vein Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Peripheral Arterial Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Other Arterial Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 7. Global Fibrinolytic Therapy Market , By End User, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Speciality Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 8. Global Fibrinolytic Therapy Market , By Administration, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Intra-arterial (IA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 9. Global Fibrinolytic Therapy Market , By Distribution Channel, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 10. Global Fibrinolytic Therapy Market , By Patient Age, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 11. Global Fibrinolytic Therapy Market , By Packaging Types, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Pre-filled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 12. Global Fibrinolytic Therapy Market , By Application, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Emergency Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Interventional Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Thrombosis Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 13. Global Fibrinolytic Therapy Market , By Dosage Form, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Lyophilized Powder for Reconstitution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Solution for Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 14. Global Fibrinolytic Therapy Market , By Geography, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 –2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Bn)
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- 15. Competitive Landscape
- Genentech, Inc. (Roche)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- Bristol Myers Squibb Company
- Novarts AG
- AstraZeneca PLC
- Johnson & Johnson
- Daiichi Sankyo Company, Limited
- Merck & Co., Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Abbott Laboratories
- Mallinckrodt Pharmaceuticals
- Mitsubishi Tanabe Pharma Corporation
- Analyst Views
- 16. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on "Global Fibrinolytic Therapy Market” - Global forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
